Date published: 2026-5-9

1-800-457-3801

SCBT Portrait Logo
Seach Input

JAK3 Activators

Common JAK3 Activators include, but are not limited to Imatinib CAS 152459-95-5, Ruxolitinib CAS 941678-49-5, Stat3 Inhibitor VI, S3I-201 CAS 501919-59-1, Stat3 inhibitor V, stattic CAS 19983-44-9 and AG-490 CAS 133550-30-8.

JAK3 activators are compounds designed to stimulate the activity or enhance the expression of Janus kinase 3 (JAK3). JAK3 is a member of the Janus kinase family, which consists of tyrosine kinases involved in initiating intracellular signaling cascades in response to extracellular cytokine stimulation. These kinases play essential roles in various cellular processes, including cell proliferation, differentiation, migration, and apoptosis. Specifically, JAK3 is associated with the signaling of certain cytokines that bind to the common gamma chain (γc) of cytokine receptors, such as interleukin-2 (IL-2), interleukin-4 (IL-4), interleukin-7 (IL-7), interleukin-9 (IL-9), interleukin-15 (IL-15), and interleukin-21 (IL-21).

The central role of JAK3 in mediating the signaling of these cytokines emphasizes its importance in modulating immune responses. Activation of JAK3 leads to the phosphorylation of signal transducers and activators of transcription (STATs), which subsequently dimerize and translocate to the nucleus, modulating the expression of target genes. JAK3 activators, by enhancing the kinase's activity or expression, can potentiate these signaling events, influencing a broad spectrum of cellular responses linked to the immune system. A deep understanding of JAK3 activation mechanisms is crucial in dissecting the complex interplay of intracellular signaling pathways that regulate immune functions. Investigating the realm of JAK3 activators sheds light on its pivotal role in orchestrating immune responses, emphasizing its central position in the cascade of events that define cellular reactions to external cytokine stimuli. This exploration underscores the delicate balance inherent in cellular signaling and the intricate network of interactions that ensure appropriate cellular responses to environmental cues.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Imatinib

152459-95-5sc-267106
sc-267106A
sc-267106B
10 mg
100 mg
1 g
$26.00
$119.00
$213.00
27
(1)

Although primarily a tyrosine kinase inhibitor, its broad effects might impact JAK3 expression in certain contexts.

Ruxolitinib

941678-49-5sc-364729
sc-364729A
sc-364729A-CW
5 mg
25 mg
25 mg
$251.00
$500.00
$547.00
16
(1)

Directly inhibits JAK1 and JAK2 but might indirectly influence JAK3 expression through feedback mechanisms.

Stat3 Inhibitor VI, S3I-201

501919-59-1sc-204304
10 mg
$151.00
104
(1)

By inhibiting STAT3, it can modulate JAK-STAT signaling potentially influencing JAK3 expression.

Stat3 inhibitor V, stattic

19983-44-9sc-202818
sc-202818A
sc-202818B
sc-202818C
sc-202818D
sc-202818E
sc-202818F
25 mg
100 mg
250 mg
500 mg
1 g
2.5 g
5 g
$130.00
$196.00
$274.00
$512.00
$731.00
$1408.00
$2091.00
114
(3)

Inhibits STAT3 activation and dimerization, potentially impacting JAK3 expression through feedback.

Cyclosporin A

59865-13-3sc-3503
sc-3503-CW
sc-3503A
sc-3503B
sc-3503C
sc-3503D
100 mg
100 mg
500 mg
10 g
25 g
100 g
$63.00
$92.00
$250.00
$485.00
$1035.00
$2141.00
69
(5)

Immunosuppressive drug that might have indirect effects on JAK3 expression.

Piceatannol

10083-24-6sc-200610
sc-200610A
sc-200610B
1 mg
5 mg
25 mg
$51.00
$71.00
$199.00
11
(2)

Inhibits both Syk and JAK1, potentially influencing JAK3 expression.

Niclosamide

50-65-7sc-250564
sc-250564A
sc-250564B
sc-250564C
sc-250564D
sc-250564E
100 mg
1 g
10 g
100 g
1 kg
5 kg
$38.00
$79.00
$188.00
$520.00
$1248.00
$5930.00
8
(1)

Known to inhibit STAT3 signaling, which might indirectly influence JAK3 expression.